Cerner CareAware iBus solution receives CE Marking certification from BSI Cerner Company today announced that the CareAware iBus has received CE Marking certification from BSI based on evaluation under Council Directive 93/42/EEC Annex II Section 3.2. The Cerner CareAware iBus answer connects important medical device information about patient wellness from disparate systems to the patient’s electronic health record . This alternative will be immediately available to healthcare organizations in the EU allowing them to gain access to medical information from medical devices and EHRs to create informed care decisions. As a global leader in the advancement of device connection and workflow solutions, we are excited to extend the providing of our CareAware iBus solution into the European marketplace, said Tom Herzog, Cerner vice president for this and healthcare products.‘Current options for administration of growing vestibular schwannomas include procedure or radiation therapy, both which are connected with potentially serious complications.’ The findings, in the February issue of the journal Otology and Neurotology which are defined, were predicated on a retrospective series of 689 people, 347 of whom were adopted with multiple magnetic resonance imaging MRI scans . The main outcome measures were individual use of aspirin and price of vestibular schwannoma development measured by adjustments in the biggest tumor dimension as observed on serial MRIs. A significant inverse association was discovered among aspirin users and vestibular schwannoma growth , that was not confounded by gender or age.